A Randomized Phase III Study of Venetoclax-Based Time-Limited Combination Treatments (RVe, GVe, GIVe) Vs Standard Chemoimmunotherapy (CIT: FCR/BR) in Frontline Chronic Lymphocytic Leukemia (CLL) of Fit Patients: First Co-Primary Endpoint Analysis of the International Intergroup GAIA (CLL13) Trial
- Barbara Eichhorst (Speaker)
- Carsten Utoft Niemann (Co-author)
- Arnon P. Kater (Co-author)
- Moritz Fürstenau (Co-author)
- Julia Von Tresckow (Co-author)
- Can v (Co-author)
- Sandra Robrecht (Co-author)
- Michael Gregor (Co-author)
- Gunnar Juliusson (Co-author)
- Patrick Thornton (Co-author)
- Philipp B. Staber (Co-author)
- Tamar Tadmor (Co-author)
- Vesa Lindström (Co-author)
- Caspar da Cunha-Bang (Co-author)
- Christof Schneider (Co-author)
- Christian Bjørn Poulsen (Co-author)
- Thomas Thomas Illmer (Co-author)
- Björn Schöttker (Co-author)
- Ann Janssens (Co-author)
- Ilse Christiansen (Co-author)
- Thomas Noesslinger (Co-author)
- Michael Baumann (Author)
- Marjolein van der Klift (Co-author)
- Ulrich Jaeer Jaeger (Co-author)
- Frederiksen, H. (Co-author)
- Maria B.L. Leijs (Co-author)
- Mels Hoogendoorn (Co-author)
- Kourosh Lotfi (Co-author)
- Holger Hebart (Co-author)
- Tobias Gaska (Co-author)
- Harry R. Koene (Co-author)
- Florian Simon (Co-author)
- Nisha De Silva (Co-author)
- Anna-Maria Fink (Co-author)
- Kirsten Fischer (Co-author)
- Clemens-Martin Wendtner (Co-author)
- Karl-Anton Kreuzer (Co-author)
- Matthias Ritgen (Co-author)
- Monika Brüggemann Brüggemann (Co-author)
- Eugen Tausch (Co-author)
- Mark-David Levin (Co-author)
- Marinus H.J. V (Co-author)
- Christian Hartmann Geisler (Co-author)
- Stephan Stilgenbauer (Co-author)
- Michael Hallek (Co-author)
Activity: Talks and presentations › Conference presentations